Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
NGUYEN, Kien T
NCT05984004: Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans	Completed	N/A	60	RoW	0.9% NaCl isotonic saline solution, 0.9% NaCl, Bacillus subtilis DSM32444, inactivated, Sperovid, Speromed, Sperokid, SPOR-COV	Huro Biotech Joint Stock Company, Thai Binh University of Medicine and Pharmacy	Rhino Sinusitis	11/22	04/23
NCT05999955: Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis	Completed	N/A	60	RoW	Neomycin/ Dexameythasone/Xylometazoline, Bacillus subtilis DSM32444, Sperovid, Speromed, Sperokid, inactivated DSM32444	Huro Biotech Joint Stock Company, Vietstar Biomedical Research	Rhinosinusitis, Rhinitis	04/23	05/23